Skip to menu Skip to content Skip to footer

2026

Conference Publication

Geomagnetic Disturbance and Ultraviolet Exposures Influence Multiple Sclerosis Onset Timing

Sajedi, Seyed Aidin, Zhu, Chao, Abdollahi, Fahimeh, Saberi, Fatemeh, Horakova, Dana, Ozakbas, Serkan, Zakaria, Magd, Shaygannejad, Vahid, Etemadifar, Masoud, Khoury, Samia J., Weinstock-Guttman, Bianca, Patti, Francesco, Boz, Cavit, Eichau, Sara, Tomassini, Valentina, Terzi, Murat, Duquette, Pierre, Kermode, Allan G., Karelis, Guntis, Amato, Maria Pia, Libertinova, Jana, Grand'Maison, Francois, Shalaby, Nevin, Kalincik, Tomas, Buzzard, Katherine, Habek, Mario, Blanco, Yolanda, Grammond, Pierre, Lechner-Scott, Jeannette ... Butzkueven, Helmut (2026). Geomagnetic Disturbance and Ultraviolet Exposures Influence Multiple Sclerosis Onset Timing. MS Australia's 10th Progress in MS Research Conference, Brisbane Australia, Dec 03-05, 2025. LONDON: SAGE PUBLICATIONS LTD.

Geomagnetic Disturbance and Ultraviolet Exposures Influence Multiple Sclerosis Onset Timing

2026

Conference Publication

Treatment strategies after cell-trafficking agents in MS-patients aged ≥ 50 years

Muller, Jannis, Buzzard, Kathrine, Skibina, Olga, Lechner-Scott, Jeannette, Hodgkinson, Suzanne, Barnett, Michael, Van Der Walt, Anneke, Butzkueven, Helmut, John, Nevin, Mccombe, Pamela, Kermode, Allan G., Fabris-Pedrini, Marzena, Carroll, William M., Macdonell, Richard, Slee, Mark, Kuhle, Jens, Amato, Maria Pia, Trojano, Maria, Kalincik, Tomas and Roos, Izanne (2026). Treatment strategies after cell-trafficking agents in MS-patients aged ≥ 50 years. MS Australia's 10th Progress in MS Research Conference, Brisbane Australia, Dec 03-05, 2025. LONDON: SAGE PUBLICATIONS LTD.

Treatment strategies after cell-trafficking agents in MS-patients aged ≥ 50 years

2026

Conference Publication

Cessation of anti-trafficking therapies after the age of 50 years

Muller, Jannis, Sharmin, Sifat, Buzzard, Katherine, Skibina, Olga, Lechner-Scott, Jeannette, Hodgkinson, Suzanne, Barnett, Michael, Van Der Walt, Anneke, Butzkueven, Helmut, John, Nevin, Mccombe, Pamela, Kermode, Allan, Fabis-Pedrini, Marzena, Macdonell, Richard, Slee, Mark, Garber, Justin, Kuhle, Jens, Kappos, Ludwig, Amato, Maria Pia, Trojan, Maria, Kalincik, Tomas and Roos, Izanne (2026). Cessation of anti-trafficking therapies after the age of 50 years. MS Australia's 10th Progress in MS Research Conference, Brisbane Australia, Dec 03-05, 2025. LONDON: SAGE PUBLICATIONS LTD.

Cessation of anti-trafficking therapies after the age of 50 years

2026

Conference Publication

Causal effects of multiple sclerosis therapies in left-truncated registry data

Haile, Dagmawi, Diouf, Ibrahima, Buzzard, Katherine, Skibina, Olga, Van Der Walt, Anneke, Butzkueven, Helmut, Macdonell, Richard, Barnett, Michael, Shaw, Cameron, Massey, Jennifer, Hardy, Todd A., Vucic, Steve, Reddel, Stephen, Ramanathan, Sudarshini, Hodgkinson, Suzanne, Garber, Justin, John, Nevin, Lechner-Scott, Jeannette, Slee, Mark, Kermode, Allan G., Fabis-Pedrini, Marzena, Carroll, William M., McCombe, Pamela, Foong, Yi Chao, Taylor, Bruce, Ferrando, Beatriz Romero, Stuart, Elizabeth, Sharmin, Sifat, Roos, Izanne and Kalincik, Tomas (2026). Causal effects of multiple sclerosis therapies in left-truncated registry data. MS Australia's 10th Progress in MS Research Conference, Brisbane Australia, Dec 03-05, 2025. LONDON: SAGE PUBLICATIONS LTD.

Causal effects of multiple sclerosis therapies in left-truncated registry data

2026

Journal Article

Systemic immune-metabolic interactions in patients with amyotrophic lateral sclerosis: correlations of plasma cytokines with metabolic status

Howe, Stephanie L., Holdom, Cory J., McCombe, Pamela A., Henderson, Robert D., Steyn, Frederik J. and Ngo, Shyuan T. (2026). Systemic immune-metabolic interactions in patients with amyotrophic lateral sclerosis: correlations of plasma cytokines with metabolic status. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 27 (5-6), 581-591. doi: 10.1080/21678421.2026.2627902

Systemic immune-metabolic interactions in patients with amyotrophic lateral sclerosis: correlations of plasma cytokines with metabolic status

2026

Journal Article

Autosomal recessive spastic ataxia of Charlevoix-Saguenay in two half-siblings

Yeow, Dennis, Katz, Matthew, Rodgers, Jonathan, Davis, Mark, Robertson, Thomas, Gardner, R. J. McKinlay and McCombe, Pamela A. (2026). Autosomal recessive spastic ataxia of Charlevoix-Saguenay in two half-siblings. Annals of Clinical and Translational Neurology, 13 (2) acn3.70236, 413-417. doi: 10.1002/acn3.70236

Autosomal recessive spastic ataxia of Charlevoix-Saguenay in two half-siblings

2026

Journal Article

Assessment of language and executive functions in ALS: the brief executive Language screen

Robinson, Gail A., Phillips, Mia R., Horne, Kristina, Ceslis, Amelia, McCombe, Pamela A. and Henderson, Robert D. (2026). Assessment of language and executive functions in ALS: the brief executive Language screen. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 27 (5-6), 1-11. doi: 10.1080/21678421.2025.2607398

Assessment of language and executive functions in ALS: the brief executive Language screen

2026

Journal Article

Moderate–high efficacy disease-modifying therapies reduce relapse risk in late-onset multiple sclerosis

Foong, Yi Chao, Merlo, Daniel, Gresle, Melissa, Buzzard, Katherine, Horakova, Dana, Havrdova, Eva Kubala, Kalincik, Tomas, Roos, Izanne, Hodgkinson, Suzanne, Lechner-Scott, Jeannette, Lugaresi, Alessandra, Weinstock-Guttman, Bianca, Ozakbas,, Serkan, Surcinelli, Andrea, Foschi, Matteo, Boz, Cavit, Khoury, Samia Joseph, Yamout, Bassem, Laureys, Guy, Blanco, Yolanda, Skibina, Olga, Kuhle, Jens, John, Nevin, Alroughani, Raed, Prevost, Julie, Van Pesch, Vincent, Tomassini, Valentina, Prat, Alexandre, Girard, Marc ... Study Group, MSBase (2026). Moderate–high efficacy disease-modifying therapies reduce relapse risk in late-onset multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 97 (1) jnnp-2025-336513, 1-9. doi: 10.1136/jnnp-2025-336513

Moderate–high efficacy disease-modifying therapies reduce relapse risk in late-onset multiple sclerosis

2025

Journal Article

Real-world effectiveness of horizontal switching between disease-modifying therapies in multiple sclerosis: a retrospective analysis of the MSBase Registry

Gomez-Figueroa, Enrique, Orozco-Puga, Patricia, Corona-Vazquez, Cynthia Patricia, Moreno-Bernardino, Carlos, Elizabeth De La Mora-landin, Graciela, Jimenez-Ruiz, Amado, Garcia-Estrada, Christian, Zertuche-Ortuno, Lizeth, Saldivar-Davila, Sergio, Rodriguez-Rivas, Roberto, Bazan-Rodriguez, Lisette, Flores-Rivera, Jose, Kalincik, Tomas, Buzzard, Katherine, Khoury, Samia, Duquette, Pierre, Foschi, Matteo, Surcinelli, Andrea, Weinstock-Guttman, Bianca, Gouider, Riadh, Mrabet, Saloua, Lechner-Scott, Jeannette, Butzkueven, Helmut, Alroughani, Raed, Roos, Izanne, Patti, Francesco, Yamout, Bassem, Grand'maison, Francois, Spitaleri, Daniele ... Ruiz-Sandoval, Jose Luis (2025). Real-world effectiveness of horizontal switching between disease-modifying therapies in multiple sclerosis: a retrospective analysis of the MSBase Registry. Therapeutic Advances in Neurological Disorders, 18 17562864251399595. doi: 10.1177/17562864251399595

Real-world effectiveness of horizontal switching between disease-modifying therapies in multiple sclerosis: a retrospective analysis of the MSBase Registry

2025

Conference Publication

Clinically silent MRI lesions in RRMS: prognostic impact and an emulated trial of disease modifying therapy escalation

Daruwalla, Cyrus, Kremler, Courtney, Patti, Francesco, Libertínová, Jana, Ozakbas, Serkan, Peterka, Marek, Vachova, Marta, Boz, Cavit, Scott, Jeannette Lechner, Roos, Izanne, Foschi, Matteo, Surcinelli, Andrea, Neri, Stefano, Khoury, Samia, Walt, Anneke van der, Butzkueven, Helmut, Meca-Lallana, Jose E, Rous, Zuzana, Habek, Mario, Alroughani, Raed, Grammond, Pierre, Blanco, Yolanda, Laureys, Guy, Buzzard, Katherine, Skibina, Olga, Gray, Orla, McCombe, Pamela, Ayuso, Guillermo Izquierdo, Eichau, Sara ... on behalf of the MSBase study group (2025). Clinically silent MRI lesions in RRMS: prognostic impact and an emulated trial of disease modifying therapy escalation. Annual Meeting of the Association-of-British-Neurologists (ABN), Liverpool, England, 6-9 May 2025. London, United Kingdom: BMJ Group. doi: 10.1136/jnnp-2025-abn.247

Clinically silent MRI lesions in RRMS: prognostic impact and an emulated trial of disease modifying therapy escalation

2025

Journal Article

Corticosteroid treatment of multiple sclerosis relapses is associated with lower disability worsening over 5 years

Roberts, Jodie I, Sharmin, Sifat, Horakova, Dana, Kubala Havrdova, Eva, Ozakbas, Serkan, Lugaresi, Alessandra, Tomassini, Valentina, Alroughani, Raed, Buzzard, Katherine, Skibina, Olga, Boz, Cavit, Turkoglu, Recai, Maimone, Davide, Yamout, Bassem, Khoury, Samia Joseph, Spitaleri, Daniele, Lechner-Scott, Jeannette, Girard, Marc, Duquette, Pierre, Al-Asmi, Abdullah, Ampapa, Radek, Foschi, Matteo, Surcinelli, Andrea, Patti, Francesco, Van Pesch, Vincent, Ramo-Tello, Cristina, Sánchez-Menoyo, José Luis, Altintas, Ayse, Grammond, Pierre ... MSBase Study Group (2025). Corticosteroid treatment of multiple sclerosis relapses is associated with lower disability worsening over 5 years. Journal of Neurology, Neurosurgery and Psychiatry, 96 (12), 1-9. doi: 10.1136/jnnp-2025-336343

Corticosteroid treatment of multiple sclerosis relapses is associated with lower disability worsening over 5 years

2025

Journal Article

Co-design and non-randomised pilot evaluation of resources developed to optimise saliva management in people with motor neurone disease

Taubert, Shana, Collins, Annette, Henderson, Robert, McCombe, Pamela, Tang, Lily, Wishart, Laurelie, Kramer, Katrina and Burns, Clare (2025). Co-design and non-randomised pilot evaluation of resources developed to optimise saliva management in people with motor neurone disease. Healthcare, 13 (21) 2813, 1-14. doi: 10.3390/healthcare13212813

Co-design and non-randomised pilot evaluation of resources developed to optimise saliva management in people with motor neurone disease

2025

Conference Publication

MS outcomes in breast cancer survivors and the influence of chemotherapy

Nesbitt, Cassie, Sanfilippo, Paul, Zhu, Chao, Ozakbas, Serkan, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Kalincik, Tomas, Roos, Izanne, Buzzard, Katherine, Skibina, Olga, Foschi, Matteo, Surcinelli, Andrea, Boz, Cavit, Lechner-Scott, Jeannette, Libertinova, Jana, Patti, Francesco, Kermode, Allan, Pedrini, Marzena, Carroll, William, Barnett, Michael, Taylor, Bruce, Hodgkinson, Suzanne, Barnett, Michael, Mccombe, Pamela, Reddel, Stephen, Vucic, Steve, Ramanathan, Sudarshini, Macdonell, Richard ... Jokubaitis, Vilija (2025). MS outcomes in breast cancer survivors and the influence of chemotherapy. ANZAN Annual Scientific Meeting 2025, Brisbane, QLD, Australia, 10-13 June 2025. London, United Kingdom: BMJ Group. doi: 10.1136/bmjno-2025-anzan.6

MS outcomes in breast cancer survivors and the influence of chemotherapy

2025

Journal Article

Epigenetic profiles of tissue informative CpGs inform ALS disease status and progression

Caggiano, Christa, Morselli, Marco, Qian, Xiaoyu, Celona, Barbara, Thompson, Michael J., Wani, Shivangi, Tosevska, Anela, Taraszka, Kodi, Heuer, Galen, Ngo, Shyuan T., Steyn, Frederick J., Nestor, Peter J., Wallace, Leanne, Mccombe, Pamela, Heggie, Susan, Thorpe, Kathryn, Mcelligott, Caitlin, English, Gemyka, Henders, Anjali, Henderson, Robert, Lomen-Hoerth, Catherine, Wray, Naomi R., Mcrae, Allan F., Pellegrini, Matteo, Garton, Fleur C. and Zaitlen, Noah (2025). Epigenetic profiles of tissue informative CpGs inform ALS disease status and progression. Genome Medicine, 17 (1) 115, 1-20. doi: 10.1186/s13073-025-01542-5

Epigenetic profiles of tissue informative CpGs inform ALS disease status and progression

2025

Conference Publication

Targeted nanopore long-read sequencing improves diagnosis of genetic myopathies

Yeow, Dennis, Stevanovski, Igor, Reis, Andre LM, Rudaks, Laura I, Chintalaphani, Sanjog R, Grosz, Bianca, Liang, Christina, Morris, Katrina A, Reddel, Stephen, McCombe, Pamela A, Zhu, Danqing, Stoll, Marion, Davis, Ryan L, Manser, David, Tchan, Michel, Worgan, Lisa, Hannaford, Andrew, Sue, Carolyn M, Shandiz, Ehsan, Ahmad, Kate E, Ghaoui, Roula, Barnes, Stephanie L, Sturm, Jonathan, Willard, Anna, Hawke, Simon, Ng, Karl, Cheong, Pak Leng, Kennerson, Marina L, Kumar, Kishore R and Deveson, Ira W (2025). Targeted nanopore long-read sequencing improves diagnosis of genetic myopathies. ANZAN Annual Scientific Meeting 2025, Brisbane, QLD, Australia, 10-13 June 2025. London, United Kingdom: BMJ Group. doi: 10.1136/bmjno-2025-anzan.5

Targeted nanopore long-read sequencing improves diagnosis of genetic myopathies

2025

Conference Publication

Preserving neurological function in people at high and low risk of aggressive multiple sclerosis

Roos, Izanne, Sharmin, Sifat, Lechner-Scott, Jeannette, Buzzard, Katherine, Skibina, Olga, Walt, Anneke van der, Butzkueven, Helmut, Barnett, Michael, Macdonell, Richard, John, Nevin, Hodgkinson, Suzanne, Slee, Mark, McCombe, Pamela, Garber, Justin, Kermode, Allan G., Fabis-Pedrini, Marzena J., Carroll, William M., Taylor, Bruce, Vukusic, Sandra and Kalincik, Tomas (2025). Preserving neurological function in people at high and low risk of aggressive multiple sclerosis. ANZAN Annual Scientific Meeting 2025, Sydney, NSW Australia, 23-26 June 2025. London, United Kingdom: BMJ Group. doi: 10.1136/bmjno-2025-anzan.153

Preserving neurological function in people at high and low risk of aggressive multiple sclerosis

2025

Journal Article

Menopause impact on multiple sclerosis disability progression

Bridge, Francesca, Sanfilippo, Paul G., Zhu, Chao, Skibina, Olga, Nguyen, Ai-Lan, Kalincik, Tomas, Buzzard, Katherine, Taylor, Bruce V., MacIntyre, Jennifer, Hall, Lesley-Ann, Slee, Mark, Macdonell, Richard, Maltby, Vicki, Lechner-Scott, Jeannette, McCombe, Pamela, Butzkueven, Helmut, van der Walt, Anneke and Jokubaitis, Vilija G. (2025). Menopause impact on multiple sclerosis disability progression. JAMA Neurology, 82 (12), 1219-1226. doi: 10.1001/jamaneurol.2025.3538

Menopause impact on multiple sclerosis disability progression

2025

Journal Article

Living with dysphagia and dysarthria: a qualitative exploration of the perspectives of people with motor neuron disease and their caregivers

Packer, Rebecca, Rumbach, Anna, Farrell, Anna, Hutchinson, Nicole, Verner-Wren, Stacey, Henderson, Robert and McCombe, Pamela (2025). Living with dysphagia and dysarthria: a qualitative exploration of the perspectives of people with motor neuron disease and their caregivers. Healthcare, 13 (18) 2306, 1. doi: 10.3390/healthcare13182306

Living with dysphagia and dysarthria: a qualitative exploration of the perspectives of people with motor neuron disease and their caregivers

2025

Conference Publication

Real-world Experience with Cladribine Tablets in the MSBase Registry 2025 Update

Spelman, Tim, van der Walt, Anneke, Ozakbas, Serkan, Horakova, Dana, Alroughani, Raed, Kalincik, Tomas, Boz, Cavit, Buzzard, Katherine, Kermode, Allan, Gerlach, O., Foschi, Matteo, Jakob, Gregor Brecl, Grigoriadis, Nikolaos, Prevost, Julie, Duquette, Pierre, Lapointe, Emmanuelle, D'Amico, Emanuele, Ampapa, Radek, Gross-Paju, Katrin, Grammond, Pierre, Cardenas-Robledo, Simon, Houskova, Jana, Khoury, Samia, Maimone, Davide, Sanchez, Jose Luis, McCombe, Pamela, Slee, Mark, Taylor, Bruce, Blanco, Yolanda ... Butzkueven, Helmut (2025). Real-world Experience with Cladribine Tablets in the MSBase Registry 2025 Update. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD.

Real-world Experience with Cladribine Tablets in the MSBase Registry 2025 Update

2025

Conference Publication

Single silent lesions matter: a comprehensive assessment of the prognostic impact of clinically silent MRI lesions in RRMS, and an emulated trial of treatment escalation

Daruwalla, Cyrus, Kremler, Courtney, Patti, Francesco, Libertinova, Jana, Ozakbas, Serkan, Peterka, Marek, Vachova, Marta, Boz, Cavit, Scott, Jeannette Lechner, Roos, Izanne, Foschi, Matteo, Surcinelli, Andrea, Neri, Stefano, Khoury, Samia, van der Walt, Anneke, Butzkueven, Helmut, Meca-Lallana, Jose E., Rous, Zuzana, Habek, Mario, Alroughani, Raed, Grammond, Pierre, Blanco, Yolanda, Laureys, Guy, Buzzard, Katherine, Skibina, Olga, Gray, Orla, Mccombe, Pamela, Izquierdo Ayuso, Guillermo, Eichau, Sara ... Brown, William (2025). Single silent lesions matter: a comprehensive assessment of the prognostic impact of clinically silent MRI lesions in RRMS, and an emulated trial of treatment escalation. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD.

Single silent lesions matter: a comprehensive assessment of the prognostic impact of clinically silent MRI lesions in RRMS, and an emulated trial of treatment escalation